301096 百誠醫藥
按盤價 
49.240 +1.240 (+2.583%)
49.240 +1.240 (+2.583%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.021 | -2.004 | 10.528 | 8.089 | 8.358 |
| 總資產報酬率 ROA (%) | -0.699 | -1.427 | 8.243 | 6.633 | 6.233 |
| 投入資產回報率 ROIC (%) | -0.735 | -1.542 | 8.966 | 7.062 | 6.632 | 邊際利潤分析 |
| 銷售毛利率 (%) | 41.617 | 51.982 | 65.528 | 67.373 | 67.265 |
| 營業利潤率 (%) | -21.684 | -4.289 | 29.193 | 31.057 | 31.789 |
| 息稅前利潤/營業總收入 (%) | -18.909 | -3.972 | 26.977 | 24.546 | 32.013 |
| 淨利潤/營業總收入 (%) | -20.351 | -6.600 | 26.735 | 31.946 | 29.646 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 129.708 | 22.084 | 102.449 | 90.733 | 96.330 |
| 價值變動淨收益/利潤總額(%) | -3.888 | 15.506 | -0.036 | -2.081 | -0.547 |
| 營業外收支淨額/利潤總額(%) | -0.465 | 4.624 | -0.454 | 1.185 | -0.035 | 償債能力分析 |
| 流動比率 (X) | 1.902 | 2.009 | 1.900 | 5.538 | 4.708 |
| 速動比率 (X) | 1.669 | 1.778 | 1.790 | 5.311 | 4.660 |
| 資產負債率 (%) | 32.347 | 30.684 | 26.845 | 15.273 | 20.756 |
| 帶息債務/全部投入資本 (%) | 25.838 | 22.861 | 15.212 | 3.570 | 12.664 |
| 股東權益/帶息債務 (%) | 273.125 | 321.431 | 529.979 | 2,540.417 | 662.769 |
| 股東權益/負債合計 (%) | 209.151 | 225.906 | 272.510 | 554.820 | 381.801 |
| 利息保障倍數 (X) | -7.069 | -7.575 | -12.943 | -3.566 | 135.989 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 259.524 | 126.015 | 61.820 | 67.053 | 53.508 |
| 存貨周轉天數 (天) | 224.370 | 126.454 | 81.715 | 80.748 | 38.888 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 11/07/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
